Analyst Recommendations

Morgan Stanley analyst issues POSITIVE recommendation for TSLA on April 12, 2024 08:16AM ET. The previous analyst recommendation was Positive.TSLA was trading at $173.7501 at issue of the...

April 12, 2024   TSLA 4.80%

Piper Sandler analyst issues OVERWEIGHT recommendation for SCHW on April 12, 2024 08:18AM ET. The previous analyst recommendation was Overweight.SCHW was trading at $70.5525 at issue of the...

April 12, 2024   SCHW 0.73%

Citigroup analyst issues NEUTRAL recommendation for JPM on April 12, 2024 08:29AM ET. The previous analyst recommendation was Neutral.JPM was trading at $187.68 at issue of the analyst...

April 12, 2024   JPM 1.74%

Wells Fargo analyst issues MARKET OUTPERFORM recommendation for DOCU on April 12, 2024 08:01AM ET. The previous analyst recommendation was Market Outperform.DOCU was trading at $59.48 at issue...

April 12, 2024   DOCU -4.31%

Wedbush analyst issues UNDERPERFORM recommendation for DOCU on April 12, 2024 08:01AM ET. The previous analyst recommendation was Underperform.DOCU was trading at $59.48 at issue of the analyst...

April 12, 2024   DOCU -4.31%

Evercore ISI analyst issues OUTPERFORM recommendation for JPM on April 12, 2024 08:01AM ET. The previous analyst recommendation was Outperform.JPM was trading at $195.43 at issue of the...

April 12, 2024   JPM 1.74%

Barclays analyst issues OVERWEIGHT recommendation for PG on April 12, 2024 05:12AM ET. The previous analyst recommendation was Overweight.PG was trading at $155.84 at issue of the analyst...

April 12, 2024   PG 0.52%

Barclays analyst issues OVERWEIGHT recommendation for KO on April 12, 2024 05:13AM ET. The previous analyst recommendation was Overweight.KO was trading at $59.05 at issue of the analyst...

April 12, 2024   KO 0.37%

BMO Capital analyst issues OUTPERFORM recommendation for MSFT on April 12, 2024 05:16AM ET. The previous analyst recommendation was Outperform.MSFT was trading at $427.93 at issue of the...

April 12, 2024   MSFT -0.38%

RBC Capital analyst issues OUTPERFORM recommendation for CRM on April 12, 2024 06:32AM ET. The previous analyst recommendation was Outperform.CRM was trading at $299.15 at issue of the...

April 12, 2024   CRM -2.74%